|
<PAGE>
Exhibit 4.5
NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS WARRANT
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED. NO SALE OR
DISPOSITION MAY BE EFFECTED EXCEPT IN COMPLIANCE WITH RULE 144
UNDER SAID ACT OR
WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR
AN OPINION OF
COUNSEL FOR THE HOLDER, SATISFACTORY TO THE COMPANY, THAT SUCH
REGISTRATION IS
NOT REQUIRED UNDER THE ACT OR RECEIPT OF A NO-ACTION LETTER FROM
THE SECURITIES
AND EXCHANGE COMMISSION.
WARRANT TO PURCHASE 4,817 SHARES OF
SERIES A CONVERTIBLE PREFERRED STOCK
January 8, 2004
THIS CERTIFIES THAT, for value received, GENERAL ELECTRIC
CAPITAL CORPORATION
("Holder") is entitled to subscribe for and purchase four
thousand eight hundred
seventeen (4,817) shares of the fully paid and no assessable
Series A
Convertible Preferred Stock (the "Shares" or the "Series A
Preferred Stock") of
Predix Pharmaceuticals Holdings, Inc., a Delaware corporation
(the "Company"),
at the Warrant Price (as hereinafter defined), pursuant to that
certain
equipment lease financing agreement by and between the Holder
and the Company
dated December 3, 2002, subject to the provisions and upon the
terms and
conditions hereinafter set forth.
1. Warrant Price. The Warrant Price shall initially be Ten and
00/100 dollars
($10.00) per share, subject to adjustment as provided in Section
7 below.
2. Conditions to Exercise. The purchase right represented by
this Warrant may be
exercised at any time, or from time to time, in whole or in part
during the term
commencing on the date hereof and ending at 5:00 P.M. Pacific
time on the tenth
anniversary of the date of this Warrant (the "Expiration
Date").
3. Method of Exercise; Payment; Issuance of Shares; Issuance of
New Warrant.
(a) Cash Exercise. Subject to Section 2 hereof, the purchase
right
represented by this Warrant may be exercised by the Holder
hereof, in whole or
in part, by the surrender of this Warrant (with a duly executed
Notice of
Exercise in the form attached hereto) at the principal office of
the Company (as
set forth in Section 18 below) and by payment to the Company, by
check, of an
amount equal to the then applicable Warrant Price per share
multiplied by the
number of shares then being purchased. In the event of any
exercise of the
rights represented by this Warrant, certificates for the shares
of stock so
purchased shall be in the name of, and delivered to, the Holder
hereof, or as
such Holder may direct (subject to the terms of transfer
contained herein and
upon payment by such Holder hereof of any applicable transfer
taxes). Such
delivery shall be made within 30 days after exercise of the
Warrant and at the
Company's expense and, unless this Warrant has been fully
exercised or expired,
a new Warrant having terms and conditions substantially
identical to this
Warrant and representing the portion of the Shares, if any, with
respect to
which this Warrant shall not have been exercised, shall also be
issued to the
Holder hereof within 30 days after exercise of the Warrant.
<PAGE>
(b) Net Issue Exercise. Holder may also elect to receive shares
equal to
the value of this Warrant (or of any portion thereof remaining
unexercised) by
surrender of this Warrant at the principal office of the Company
together with
notice of such election, in which event the Company shall issue
to Holder the
number of shares of Series A Preferred Stock computed using the
following
formula:
X = Y (A-B)
-------
A
Where X = the number of shares of Series A Preferred Stock to be
issued to
Holder.
Y = the number of shares of Series A Preferred Stock purchasable
under
this Warrant (at the date of such calculation).
A = the Fair Market Value of one share of the Series A Preferred
Stock (at
the date of such calculation).
B = Warrant Price (as adjusted to the date of such
calculation).
(c) Fair Market Value. For purposes of this Section 3, Fair
Market Value
of one share of Series A Preferred Stock shall mean:
(i) The average of the closing bid and asked prices of the
Company's
common stock, $0.01 par value (the "Common Stock") quoted in
the
Over-The-Counter Market Summary, the last reported sale price
quoted on
the Nasdaq National Market or on any exchange on which the
Common Stock
is listed, whichever is applicable, as published in the Western
Edition
of the Wall Street Journal for the ten (10) trading days prior
to the
date of determination of Fair Market Value; or
(ii) In the event of an exercise in connection with a
merger,
acquisition or other consolidation in which the Company is not
the
surviving entity, the per share Fair Market Value for the Stock
shall
be the value to be received per share of Series A Preferred
Stock by
all holders of the Series A Preferred Stock in such transaction
as
determined by the Board of Directors; or
(iii) In any other instance, the per share Fair Market Value for
the
Series A Preferred Stock shall be as determined in good faith by
the
Company's Board of Directors.
In the event of 3(c)(ii) or 3(c)(iii), above, the Company's
Board of
Directors shall prepare a certificate, to be signed by an
authorized
officer of the Company, setting forth in reasonable detail the
basis
for and method of determination of the per share Fair Market
Value of
the Stock. The Board will also certify to the Holder that this
per
share Fair Market Value will be applicable to all holders of the
Series
2
<PAGE>
A Preferred Stock. Such certification must be made to Holder at
least
thirty (30) business days prior to the proposed effective date
of the
merger, consolidation, sale, or other triggering event as
defined in
3(c)(ii) or 3(c)(iii).
(d) Automatic Exercise. So long as the Fair Market Value of the
Warrant is
equal to or greater than the Warrant Price, to the extent this
Warrant is not
previously exercised, it shall be automatically exercised in
accordance with
Sections 3(b) and 3(c) hereof (even if not surrendered)
immediately before its
expiration, involuntary termination or cancellation.
4. Representations and Warranties of Holder and the Company.
(a) Representations and Warranties by Holder. The Holder
represents and
warrants to the Company with respect to his purchase as
follows:
(i) The Holder has substantial experience in evaluating and
investing in
private placement transactions of securities of companies
similar to the
Company so that the Holder is capable of evaluating the merits
and risks
of its investment in the Company and has the capacity to protect
its
interests.
(ii) Except for transfer to a Holder's affiliates, the Holder is
acquiring
the Warrant and the Shares of Series A Preferred Stock issuable
upon
exercise of the Warrant (collectively the "Securities") for
investment for
its own account and not with a view to, or for resale in
connection with,
any distribution thereof. The Holder understands that the
Securities have
not been registered under the Securities Act of 1933, as amended
(the
"Act") by reason of a specific exemption from the registration
provisions
of the Act which depends upon, among other things, the bona fide
nature of
the investment intent as expressed herein.
(iii) The Holder acknowledges that the Securities must be
held
indefinitely unless subsequently registered under the Act or an
exemption
from such registration is available. The Holder is aware of the
provisions
of Rule 144 promulgated under the Act.
(iv) The Holder is an "accredited investor" within the meaning
of
Regulation D promulgated under the Act.
(v) The Holder has had an opportunity to discuss the Company's
business,
management and financial affairs with its management and an
opportunity to
review the Company's facilities. The Holder understands that
such
discussions, as well as the written information issued by the
Company,
were intended to describe the aspects of the Company's business
and
prospects which the Company believes to be material but were
not
necessarily a thorough or exhaustive description.
(b) Company hereby represents and warrants to Holder that the
statements in
the following paragraphs of this Section 4(b) are true and
correct as of the
date hereof.
(i) Corporate Organization and Authority. The Company (a) is a
corporation
duly organized, validly existing, and in good standing in its
jurisdiction
of
3
<PAGE>
incorporation, (b) has the corporate power and authority to own
and
operate its properties and to carry on its business as now
conducted and
as proposed to be conducted; and (c) is qualified as a foreign
corporation
in all jurisdictions where the failure to be so qualified would
have a
material adverse effect on the Company.
(ii) Corporate Power. The Company has all requisite legal and
corporate
power and authority to execute, issue and deliver the Warrant,
to issue
the Series A Preferred Stock issuable upon exercise or
conversion of the
Warrant, and to carry out and perform its obligations under the
Warrant
and any related agreements.
(iii) Authorization; Enforceability. All corporate action on the
part of
Company, its officers, directors and shareholders necessary for
the
authorization, execution, delivery and performance of its
obligations
under this Warrant and for the authorization, issuance and
delivery of the
Warrant and Stock issuable upon exercise of the Warrant has been
taken and
this Warrant constitutes the legally binding and valid
obligation of
Company enforceable in accordance with its terms.
(iv) Valid Issuance of Warrant and Series A Preferred Stock. The
Warrant
has been validly issued and is free of restrictions on transfer
other than
restrictions on transfer set forth herein and under applicable
state and
federal securities laws. The Series A Preferred Stock issuable
upon
conversion of this Warrant, when issued, sold and delivered in
accordance
with the terms of this Warrant for the consideration expressed
herein,
will be duly and validly issued, fully paid and no assessable,
and will be
free of restrictions on transfer other than restrictions on
transfer under
this Warrant and under applicable state and federal securities
laws.
Subject to applicable restrictions on transfer, the issuance and
delivery
of the Warrant and the Series A Preferred Stock issuable upon
conversion
of the Warrant are not subject to any preemptive or other
similar rights
or any liens or encumbrances except as specifically set forth in
Company's
Certificate of Incorporation, as amended and restated to date
(the
"Certificate of Incorporation"), or this Warrant. The offer,
sale and
issuance of the Warrant and Series A Preferred Stock, as
contemplated by
this Warrant, are exempt from the prospectus and registration
requirements
of applicable United States federal and state security laws, and
neither
Company nor any authorized agent acting on its behalf has or
will take any
action hereafter that would cause the loss of such
exemption.
(v) No Conflict with Other Instruments. The execution, delivery,
and
performance of this Warrant will not result in any violation of,
be in
conflict with, or constitute a default under, with or without
the passage
of time or the giving of notice (a) any provision of Company's
Certificate
of Incorporation or by-laws; (b) any provision of any judgment,
decree, or
order to which Company is a party or by which it is bound or an
event
which results in the creation of any material lien, charge or
encumbrance
upon any material assets of Company; (c) any
4
<PAGE>
contract, obligation, or commitment to which Company is a party
or by
which it is bound; or (d) any statute, rule, or governmental
regulation
applicable to Company.
(vi) Capitalization. As of the date of this Warrant, the
authorized and
issued capital stock of Company is as set forth in Exhibit A.
The
outstanding shares have been duly authorized and validly
issued
(including, without limitation, issued in compliance with
applicable
federal and state securities laws), are fully paid and
nonassessable and
have been issued in compliance with the registration and
prospectus
delivery requirements of the Securities Act and the registration
and
qualification requirements of all applicable state securities
laws, or in
compliance with applicable exemptions therefrom. The Company has
reserved
4,817 shares of Series A Preferred Stock for issuance upon
exercise of
this Warrant and 48,170 shares of Common Stock for the
conversion of the
Series A Preferred Stock to Common Stock. Except as set forth on
the
capitalization table attached to this Warrant in Exhibit A,
there are no
outstanding warrants, options, conversion privileges, preemptive
rights or
other rights or agreements to purchase or otherwise acquire or
issue any
equity securities or convertible securities of Company, nor has
the
issuance of any of the aforesaid rights to acquire securities of
Company
been authorized.
(vii) Governmental Consents. No consent, approval, order or
authorization
of, or registration, qualification, designation, declaration or
filing
with, any federal, state or local governmental authority on the
part of
Company is required in connection with the offer, sale or
issuance of the
Warrant (and the Stock issuable upon the exercise of this
Warrant), or the
consummation of any other transaction contemplated hereby,
except for the
following: (a) the filing of a notice on Form D under the Act
and (b) the
compliance with other applicable state securities laws, which
compliance
will have occurred within the appropriate time periods
therefore. The
offer, sale and issuance of the Warrant and the shares of Stock
in
conformity with the terms of this Warrant are exempt from the
registration
requirements of the Act and any applicable state laws.
(c) Within ten (10) days of the Holder providing notice to the
Company of its
intent to exercise this Warrant, the Company will deliver to the
Holder an
Officer's Certificate certifying that all of the representations
and warranties
set forth in this Section 4 are true and correct in all material
respects as of
the date of such certificate, except for Section 4(vi), in which
case the
Company will deliver to the Holder an updated capitalization
table in the same
form as set forth in Appendix A and make the representations and
warranties set
forth in Section 4(vi) as they relate to the updated
capitalization table.
5. Legends.
(a) Each certificate representing the Securities shall be
endorsed with the
following legend:
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933
AND MAY NOT BE TRANSFERRED UNLESS COVERED BY AN
5
<PAGE>
EFFECTIVE REGISTRATION STATEMENT U
|